N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial
Cites articles 32
- 2011-02-04
Date
Title
Article - wd:Q36139749